(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

UNOREADY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

UNOREADY

ST13

US500000079332925

Class

5

Filing

79332925

Registration

6784288

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

05/20/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

11/16/2021

Registration date

07/12/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/12/2022

Last transaction

09/15/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

RADEMACHER, APRIL

Law office

L80

Current location

TMEG LAW OFFICE 108

Holders and representatives

Holders

NOVARTIS AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; medical devices *being auto-injectors* pre-filled with pharmaceutical preparations

Publications

History of USPTO decisions and trademark events.

37 publications found

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

05/20/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

05/14/2024

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

10/17/2023

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

10/12/2023

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

09/14/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/14/2023

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

09/14/2023

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

06/16/2023

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

06/11/2023

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

05/30/2023

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

04/25/2023

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/24/2023

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

02/13/2023

GPNX

NOTIFICATION PROCESSED BY IB

09/25/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/06/2022

FIMP

FINAL DISPOSITION PROCESSED

09/06/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

08/11/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/12/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/12/2022

CHPB

POST PUBLICATION AMENDMENT - ENTERED

06/07/2022

APET

ASSIGNED TO PETITION STAFF

06/07/2022

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

05/18/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/26/2022

PUBO

PUBLISHED FOR OPPOSITION

04/26/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/19/2022

DOCK

ASSIGNED TO EXAMINER

03/17/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/07/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/07/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/07/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/07/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/07/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/07/2022

MAFR

APPLICATION FILING RECEIPT MAILED

03/01/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/23/2022

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

02/18/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/10/2022

Continuous trademark protection

Get notified about every new filing that threatens UNOREADY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.